Daiwa Securities Group’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-297
| Closed | -$3K | – | 1324 |
|
|
2025
Q4 | $3K | Hold |
297
| – | – | ﹤0.01% | 1278 |
|
|
2025
Q3 | $3K | Hold |
297
| – | – | ﹤0.01% | 1241 |
|
|
2025
Q2 | $2K | Hold |
297
| – | – | ﹤0.01% | 1217 |
|
|
2025
Q1 | $2K | Hold |
297
| – | – | ﹤0.01% | 1185 |
|
|
2024
Q4 | $3K | Hold |
297
| – | – | ﹤0.01% | 1198 |
|
|
2024
Q3 | $6K | Buy |
297
+70
| +31% | +$1.42K | ﹤0.01% | 1158 |
|
|
2024
Q2 | $5K | Hold |
227
| – | – | ﹤0.01% | 1198 |
|
|
2024
Q1 | $5K | Hold |
227
| – | – | ﹤0.01% | 1209 |
|
|
2023
Q4 | $3K | Hold |
227
| – | – | ﹤0.01% | 1247 |
|
|
2023
Q3 | $2K | Hold |
227
| – | – | ﹤0.01% | 1220 |
|
|
2023
Q2 | $2K | Hold |
227
| – | – | ﹤0.01% | 1237 |
|
|
2023
Q1 | $3K | Hold |
227
| – | – | ﹤0.01% | 1190 |
|
|
2022
Q4 | $3K | Hold |
227
| – | – | ﹤0.01% | 1198 |
|
|
2022
Q3 | $3K | Hold |
227
| – | – | ﹤0.01% | 1197 |
|
|
2022
Q2 | $4K | Hold |
227
| – | – | ﹤0.01% | 1183 |
|
|
2022
Q1 | $4K | Hold |
227
| – | – | ﹤0.01% | 1196 |
|
|
2021
Q4 | $3K | Hold |
227
| – | – | ﹤0.01% | 1247 |
|
|
2021
Q3 | $4K | Buy |
227
+96
| +73% | +$1.81K | ﹤0.01% | 1195 |
|
|
2021
Q2 | $3K | Hold |
131
| – | – | ﹤0.01% | 1111 |
|
|
2021
Q1 | $4K | Buy |
131
+24
| +22% | +$759 | ﹤0.01% | 1091 |
|
|
2020
Q4 | $3K | Sell |
107
-181
| -63% | -$6.36K | ﹤0.01% | 1088 |
|
|
2020
Q3 | $9K | Hold |
288
| – | – | ﹤0.01% | 1046 |
|
|
2020
Q2 | $3K | Hold |
288
| – | – | ﹤0.01% | 1140 |
|
|
2020
Q1 | $3K | Hold |
288
| – | – | ﹤0.01% | 1138 |
|
|
2019
Q4 | $4K | Hold |
288
| – | – | ﹤0.01% | 1126 |
|
|
2019
Q3 | $4K | Buy |
288
+46
| +19% | +$819 | ﹤0.01% | 1089 |
|
|
2019
Q2 | $5K | Hold |
242
| – | – | ﹤0.01% | 1098 |
|
|
2019
Q1 | $4K | Buy |
242
+75
| +45% | +$1.16K | ﹤0.01% | 1092 |
|
|
2018
Q4 | $2K | Hold |
167
| – | – | ﹤0.01% | 1108 |
|
|
2018
Q3 | $3K | Hold |
167
| – | – | ﹤0.01% | 1107 |
|
|
2018
Q2 | $3K | Hold |
167
| – | – | ﹤0.01% | 1125 |
|
|
2018
Q1 | $3K | Buy |
+167
| New | +$3.25K | ﹤0.01% | 1104 |
|
Other funds holding KURA
SCM
BI
AC
PM
DTC
Daiwa Securities Group's KURA Position: Q1 2026 in Review
Daiwa Securities Group sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 297 shares — an estimated $3K sold.
Daiwa Securities Group first reported a position in KURA in Q1 2018 and held it in 32 quarters. The position peaked at $9K in Q3 2020. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.
- Daiwa Securities Group reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 297 Kura Oncology shares in Q1 2026, an estimated $3K.
- Daiwa Securities Group first reported a position in Kura Oncology in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Kura Oncology position peaked at $9K in Q3 2020.
- 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.